Compare VNRX & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | TPCS |
|---|---|---|
| Founded | N/A | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 34.0M |
| IPO Year | 2012 | 2008 |
| Metric | VNRX | TPCS |
|---|---|---|
| Price | $0.20 | $3.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 12.0M | 59.7K |
| Earning Date | 03-27-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.00 | ★ 64.20 |
| EPS | N/A | ★ N/A |
| Revenue | $1,233,511.00 | ★ $34,031,000.00 |
| Revenue This Year | $68.22 | N/A |
| Revenue Next Year | $382.75 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 59.10 | 7.72 |
| 52 Week Low | $0.17 | $2.08 |
| 52 Week High | $0.94 | $6.25 |
| Indicator | VNRX | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 46.20 | 36.02 |
| Support Level | $0.17 | $3.23 |
| Resistance Level | $0.27 | $3.85 |
| Average True Range (ATR) | 0.02 | 0.26 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 21.99 | 25.00 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.